ACRX

AcelRx Pharmaceuticals, Inc. News Headlines

$6.78
*  
0.13
1.95%
Get ACRX Alerts
*Delayed - data as of Oct. 24, 2014  -  Find a broker to begin trading ACRX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
AcelRx Reports Publication Of Zalviso Phase 3 Abdominal Trial Results
10/22/2014 7:45:00 AM - RTT News


AcelRx Pharma Provides Update On Zalviso - Quick Facts
9/26/2014 7:29:00 AM - RTT News


Hedge Fund Legends Are Investing In These Below $7 Stocks
9/24/2014 3:32:00 PM - Seeking Alpha


An FDA Rejection Can Help Foster Confidence? The Compelling Case For AcelRx Pharmaceuticals
9/12/2014 6:15:00 AM - Seeking Alpha


AcelRx Pharma To Present At Morgan Stanley Conference; Webcast At 1:30 PM ET
9/10/2014 12:30:00 PM - RTT News


AcelRx Pharma To Present At Canaccord Growth Conference; Webcast At 2:30 PM ET
8/13/2014 1:30:00 PM - RTT News


AcelRx Pharmaceuticals (ACRX) Soars: Stock Adds 6.8% in Session - Tale of the Tape
8/1/2014 9:39:00 AM - Zacks.com


Monday Sector Laggards: Metals Fabrication & Products, Drugs
7/28/2014 1:36:47 PM - BNK Invest


Pre-Market Most Active for Jul 28, 2014 : FDO, DLTR, ACRX, HZNP, TRLA, LOCO, SNY, DG, BHP, GSK, FB, AAPL
7/28/2014 8:39:59 AM - NASDAQ.com News


Zalviso: The Good, The Bad And The Ugly Of The FDA's Complete Response Letter
7/28/2014 3:04:00 AM - Seeking Alpha


Edelman's Perceptive Advisors Buying Amicus Therapeutics Ahead Of Phase III Data Release
7/23/2014 9:01:00 AM - Seeking Alpha


Shorting AcelRx Into PDUFA: A Risky Proposition
7/23/2014 7:52:00 AM - Seeking Alpha


AcelRx Pharmaceuticals (ACRX) Jumps: Stock Adds 11.7% in Session - Tale of the Tape
7/21/2014 9:39:00 AM - Zacks.com


Friday Sector Leaders: Manufacturing, Drugs
7/18/2014 2:07:24 PM - BNK Invest


AcelRx's Upcoming PDUFA And Trade Recommendations
7/7/2014 10:13:00 AM - Seeking Alpha


AcelRx Should Trend Higher As FDA Approval Is Likely At End Of This Month
7/2/2014 8:30:00 AM - Seeking Alpha


AcelRx Pharmaceuticals (ACRX) Jumps: Stock Rises 9.0% - Tale of the Tape
6/17/2014 9:18:00 AM - Zacks.com


2nd Half Of 2014 Biotechnology Catalysts: Part 1
5/27/2014 9:34:00 AM - Seeking Alpha


Healthcare Stocks Narrowly Mixed; AcelRx Swinging Between Gains, Losses After Beating EPS Estimates
5/9/2014 12:48:47 PM - MT Newswires


Sector Update: Healthcare
5/9/2014 12:48:23 PM - MT Newswires


After Hours Most Active for Mar 10, 2014 : CX, HFC, VSH, BPO, ARO, PGR, MSFT, ACAS, MU, VOD, ACRX, RFMD
3/10/2014 4:39:09 PM - NASDAQ.com News


Significant Upcoming Catalysts For These Biotechs Should Provide Alpha Opportunity
2/14/2014 8:30:00 AM - Seeking Alpha


Mallinckrodt Beats Q1 Earnings, Ups View - Analyst Blog
2/10/2014 11:35:01 AM - Zacks.com


Cempra (CEMP) Falls: Stock Plunges 10.7% - Tale of the Tape
1/28/2014 9:47:01 AM - Zacks.com


Is AcelRx Pharmaceuticals Inc (ACRX) Ready to Breakout? - Tale of the Tape
1/13/2014 8:19:01 AM - Zacks.com